Why the study?
Although metabolic remodeling and mitochondrial dysfunction are central features of HFpEF, the direct mechanistic link between altered cardiac metabolism and mitochondrial impairment remains elusive.
Population
8-10-week-old male and female mice
Comparison
Infusion of angiotensin-II and phenylephrine
Design
Preclinical animal study
Key result
Cardiac metabolic remodeling in experimental HFpEF drove a 7-fold increase in mitochondrial protein glycation and a ~20% reduction in mitochondrial calcium retention capacity.
Authors
Loading...
Should not yet change HFpEF practice; leaves open glycative stress as targetable mitochondrial pathway for future trials.
In an experimental HFpEF model, metabolic remodeling drives dicarbonyl and glycative stress, which impairs mitochondrial function, suggesting mitochondrial dicarbonyl detoxification and anti-glycation strategies as potential therapeutic targets.
Aryal et al. (2026) studied this question. Cardiac metabolic remodeling in experimental HFpEF drove a 7-fold increase in mitochondrial protein glycation and a ~20% reduction in mitochondrial calcium retention capacity.